Navigation Links
Quotient Biodiagnostics Signs MED Alliance Group, Inc. as Exclusive Distributor in Midwest for Line of Transfusion Diagnostics
Date:10/28/2009

Alliance Group, Inc.

Those interested in learning more about Quotient Biodiagnostics and its line of products are encouraged to visit www.quotientbd.com, or call the customer service line 888-284-1901, or e-mail customer.service(at)quotientbd.com.

About Quotient Biodiagnostics
Quotient Biodiagnostics is the diagnostics division of Quotient Bioscience Group (United Kingdom), and through its wholly owned subsidiary, Alba Bioscience, brings over 30 years experience in the transfusion medicine market to the Group. Quotient will focus on providing innovative, high-quality and cost-effective solutions to the worldwide transfusion medicine market, helping to ensure safe and reliable blood transfusions. Quotient's goal is to develop innovative new products and technologies to serve the worldwide transfusion medicine market, build a commercial operation (initially in North America) to market and sell the Group's world leading range of blood typing and screening products and continue as an important supplier of key raw materials and innovative new products to the Original Equipment Manufacturers market.

###

Read the full story at http://www.prweb.com/releases/2009/10/prweb3123734.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Quotient Biodiagnostics Receives U.S. Food & Drug Administration Clearance to Enter U.S. Transfusion Diagnostics Market
2. MedAppz Signs Agreement with MedAssets to Offer SAAS-based Electronic Health Record to MedAssets' Non-acute Customers
3. Chimps Show Signs of Culture
4. Pumping Up the Volume in the Face to Reduce Signs of Aging
5. Vicon Signs License Agreement with Microsoft to Develop New Medical Technology
6. Vicon signs license agreement with Microsoft to develop new medical technology
7. Capital BlueCross Reaches Out to Former Employees of Turbine Airfoil Designs
8. Pluromed, Inc. Signs Agreement with Boston Scientific
9. SEO Consultant Top Rank Web Designs Gives Away 250 Free Websites
10. /R E P E A T -- DiagnoCure signs distribution agreement in the UK for its colorectal cancer test/
11. DiagnoCure signs distribution agreement in the UK for its colorectal cancer test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Johnson & Johnson and its Janssen Pharmaceuticals ... a Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) filed by the ... to market the antipsychotic drug. Court records filed ... Attorney General moved to dismiss the case on May ... amounts to just a fraction of the $1.2 billion ...
(Date:6/3/2015)... The National Resident Matching Program Board ... M.D., Dean of Medical Education at the University of California, ... July 1. , “It is an honor to ... Program,” said Dr. Savoia. “NRMP’s goal is to provide ... with training programs, and I welcome the opportunity to guide ...
(Date:6/3/2015)... On the heels of a report predicting ... 2020 ( click here to review news coverage about ... Baltimore has the talent to become a world-leading center ... and other biological data are collected and analyzed to help ... all the elements of a perfect storm for bioinformatics leadership,” ...
(Date:6/3/2015)... Horizon Blue Cross Blue Shield of New Jersey has ... nation’s top employers for diverse managers and women. The ... of Best Places for Diverse Managers and Women to Work ... This is the sixth consecutive year that Horizon BCBSNJ ... workplace policies and programs. , Companies are selected based on ...
(Date:6/3/2015)... June 03, 2015 VeoMed and ... expand online and mobile access to premier Continuing ... Maintenance of Certification (MOC) activities. ... innovative courses to Decker’s extensive lists of physicians, ... purchasing access to VeoMed’s premier online and live-streamed ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2
... The way locusts react to stress may provide ... and how to reduce their painful effects, says ... student Corinne Rodgers, Dr. Robertson is using insect models ... stress is induced through high temperatures and oxygen deprivation. ...
... success of the first three years of the American ... Physicians Foundation (ACPF) Diabetes Initiative, the program has received ... initiative for an additional two years through December 2009. ... our efforts confirm that optimal diabetes care requires a ...
... Capital Management, the,owner, together with its affiliates, of nearly ... Inc. (Nasdaq: VSTA ), announced today,that it had ... belief that the offer by Odyssey Healthcare, Inc. (Nasdaq: ... is wholly inadequate. Accipiter,Capital Management and its affiliates do ...
... Merit Medical,Systems, Inc. (Nasdaq: MMSI ), a ... in cardiology and radiology,procedures, announced today that the Company ... year ended December 31, 2007, after the,close of the ... will hold its investor conference call on the same ...
... Lotus Pharmaceuticals,Inc. (OTC Bulletin Board: LTUS) ("Lotus" ... People,s Republic of China ("PRC"), today,announced that ... owned,subsidiary of Lotus, has implemented cost saving ... costs by approximately 50%., The environmentally-friendly ...
... Hybrid electric vehicles that run on both conventional ... than a stop gap until more sustainable technology ... in the Inderscience publication International Journal of Automotive ... of HEVs might even slow development of more ...
Cached Medicine News:Health News:Comatose locusts may help relieve migraines 2Health News:Team-based approach improves diabetes care 2Health News:Team-based approach improves diabetes care 3Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 2Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 3Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 4Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 5Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 6Health News:Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Year Ended December 31, 2007 2Health News:Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Year Ended December 31, 2007 3Health News:Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies 2Health News:The trouble with hybrids 2
(Date:6/3/2015)... , June 02, 2015 Research and ... of the "Global Neurodegenerative Diseases Market 2015-2019" ... global neurodegenerative diseases market to grow at a ... This report covers the present scenario and ... market for the period 2015-2019. To calculate the ...
(Date:6/3/2015)... PillPack, the pharmacy that simplifies medication management, today announced ... led by CRV with participation from Accel Partners, Atlas ... be used to fuel growth, accelerate the hiring of ... markets. "In the last two years, we,ve ... folks absolutely love," says TJ Parker, PharmD, CEO of ...
(Date:6/3/2015)... Calif. , June 3, 2015  Armetheon, ... molecule drugs for cardiovascular diseases, today announced that ... been appointed Chief Executive Officer, effective immediately. Dr. ... in global, high-growth enterprises, with a successful track ... of human health. With expertise that includes the ...
Breaking Medicine Technology:Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4
... Flextend lead is a ... with an extendable/retractable active-fixation ... design offers various lead ... implantation in the atrium ...
... leads are implantable bipolar extendable/retractable screw-in ... either the atrium or the ventricle. ... be extended or retracted by turning ... contains an anti-chattering mechanism for steady ...
Used with permanent pacing leads....
... Tupos LA, the only ICD system in ... the first implant for the treatment of ... a lasting improvement of their hemodynamics and ... LA uses biatrial stimulation to effectively suppress ...
Medicine Products: